Saccharomyces boulardii for the Prevention of Antibiotic-Associated Diarrhea in Adult Hospitalized Patients: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Trial - Concepedia

Concepedia

Publication | Closed Access

Saccharomyces boulardii for the Prevention of Antibiotic-Associated Diarrhea in Adult Hospitalized Patients: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Trial

104

Citations

17

References

2012

Year

Pietro Pozzoni, Alessia Riva, Alessandro Giacco Bellatorre, Maria Amigoni, Elena Redaelli, Anna Ronchetti, Mariangela Stefani, R. Tironi, E Molteni, Dario Conte,

The American Journal of Gastroenterology

Abstract

In elderly hospitalized patients, S. boulardii was not effective in preventing the development of AAD.

References

	Year	Citations
Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial Marc G. Besselink, Hjalmar C. van Santvoort, Erik Buskens, The Lancet ProbioticSevere Acute PancreatitisAntibioticsPancreatic Fluid CollectionGastroenterology	2008	1.3K
A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease Severity Fred A. Zar, S. R. Bakkanagari, K. M. L. S. T. Moorthi, Clinical Infectious Diseases	2007	1.2K
Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficile Lorraine Kyne, M. B. Hamel, Raju Polavaram, Clinical Infectious Diseases	2002	904
A Randomized Placebo-Controlled Trial of Saccharomyces boulardii in Combination With Standard Antibiotics for Clostridium difficile Disease Lynne V. McFarland JAMA	1994	854
Use of probiotic <i>Lactobacillus</i> preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial Mary Hickson, Aloysius L D'Souza, Nirmala Muthu, BMJ	2007	584
The Search for a Better Treatment for Recurrent<i>Clostridium difficile</i>Disease: Use of High‐Dose Vancomycin Combined with<i>Saccharomyces boulardii</i> Christina M. Surawicz, Lynne V. McFarland, Richard N. Greenberg, Clinical Infectious Diseases	2000	529
A National Survey of the Prevalence and Impact of Clostridium difficile Infection Among Hospitalized Inflammatory Bowel Disease Patients Geoffrey C. Nguyen, Gilaad G. Kaplan, Mary L. Harris, The American Journal of Gastroenterology	2008	394
Dose–Response Efficacy of a Proprietary Probiotic Formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for Antibiotic-Associated Diarrhea and Clostridium difficile -Associated Diarrhea Prophylaxis in Adult Patients Xing Wang Gao, Mohamed Mubasher, Chong Yu Fang, The American Journal of Gastroenterology	2010	311
Evaluation of Hospital Room Assignment and Acquisition of <i>Clostridium difficile</i> Infection Megan Shaughnessy, Renee L. Micielli, Daryl D. DePestel, Infection Control and Hospital Epidemiology	2011	304
Clinical Risk Factors for Severe<i>Clostridium difficile</i>–associated Disease Timothy J. Henrich, Douglas Krakower, Asaf Bitton, Emerging infectious diseases Severe CdadSevere DiseaseClinical EpidemiologyGastroenterologyRisk	2009	217

Page 1